Skip to main content

Rachel H. Nusbaum, MS

Academic Title:


Primary Appointment:


Additional Title:

Assistant Program Director, Master's in Genetic Counseling Training Program


685 W. Baltimore Street

Phone (Primary):


Education and Training

2001. B.S., Integrated Science and Technology, James Madison University (Magna Cum Laude), Thesis Advisor – Maria Papadakis, Ph.D. “The genetics of Beta-Thalassaemia and patient counseling: A reference guide for Maltese health care professionals

2005. M.S., Genetic Counseling, University of Pittsburgh School of Public Health, Thesis Advisor – Mary Marazita, Ph.D. “Assessing the impact of prenatal diagnosis of clefting on the maternal/paternal birth experience

Research/Clinical Keywords

Genetic counseling, genomics, inherited cancer susceptibility

Highlighted Publications

Nusbaum R, Vogel KJ, Ready K. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes. Breast Disease. 2006, 2007; 27:21-50.

Nusbaum R and Isaacs C. Management Updates for Women with a BRCA1 or BRCA2 Mutation. Molecular Diagnosis and Therapy. 2007; 11:133-144.

Nusbaum R, Grubs RE, Losee JE, Weidman C, Ford MD,  Marazita ML. A Qualitative Description of Receiving a Diagnosis of Clefting in the Prenatal or Postnatal Period.  Journal of Genetic Counseling. 2008, 17:336–350

Nusbaum R, Peshkin BN, DeMarco TA, Goodenberger M. Oncology Genetics: BRCA1/2 testing in newly diagnosed breast cancer patients. Community Oncology. 2009; 6:367-371.

Nusbaum R, Leventhal KG, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, Tuong W, Eggly S, Mathew J, Goerlitz D, Shields PG, Schwartz MD, Graves KD. Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer risk. Translational Behavioral Medicine. 2013, 3:17-29.

Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L,  Vaccari EM, Bissonnette J, Booker JK, Cremona ML, Gibellini F,  Murphy PD, Pineda-Alvarez DE, Pollevick GD, Xu Z, Richard G, Bale S, Klein RT, Hruska KS, Chung WK. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016 Aug;18(8):823-32

Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, Hooker GW, DeMarco TA, Heinzmann J, McKinnon W, McCormick SR, Davis C, Forman AD, Lebensohn AP, Dalton E, Tully DM, Graves KD, Similuk M, Kelly S, Peshkin BN. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Fam Cancer. 2016 Mar 11. [Epub ahead of print].